Kathy Li
Investor Relations Kontakt bei Dragon Pharmaceutical, Inc.
Profil
Kathy Li is currently the Head of Investor Relations at Dragon Pharmaceutical, Inc. She previously worked as the Director of Investor Relations at Harbin Electric, Inc.
Aktive Positionen von Kathy Li
| Unternehmen | Position | Beginn |
|---|---|---|
Dragon Pharmaceutical, Inc.
 Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Kathy Li
| Unternehmen | Position | Ende |
|---|---|---|
Harbin Electric, Inc.
 Harbin Electric, Inc. Electrical ProductsProducer Manufacturing Harbin Electric, Inc. designs, develops, and manufactures linear motors and special electric motors. The company was founded on April 10, 2003 and is headquartered in Harbin, China. | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Health Technology |
Harbin Electric, Inc.
Harbin Electric, Inc. Electrical ProductsProducer Manufacturing Harbin Electric, Inc. designs, develops, and manufactures linear motors and special electric motors. The company was founded on April 10, 2003 and is headquartered in Harbin, China. | Producer Manufacturing |
